BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17786940)

  • 1. The pharmacology of radiolabeled cationic antimicrobial peptides.
    Brouwer CP; Wulferink M; Welling MM
    J Pharm Sci; 2008 May; 97(5):1633-51. PubMed ID: 17786940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 99mTc-antimicrobial peptides: promising candidates for infection imaging.
    Lupetti A; Pauwels EK; Nibbering PH; Welling MM
    Q J Nucl Med; 2003 Dec; 47(4):238-45. PubMed ID: 14973416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiopharmaceuticals: new antimicrobial agents.
    Lupetti A; Nibbering PH; Welling MM; Pauwels EK
    Trends Biotechnol; 2003 Feb; 21(2):70-3. PubMed ID: 12573855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of technetium-99m radiolabeled human antimicrobial peptides for infection specific imaging.
    Brouwer CP; Sarda-Mantel L; Meulemans A; Le Guludec D; Welling MM
    Mini Rev Med Chem; 2008 Sep; 8(10):1039-52. PubMed ID: 18782056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 99mTc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infections.
    Welling MM; Lupetti A; Balter HS; Lanzzeri S; Souto B; Rey AM; Savio EO; Paulusma-Annema A; Pauwels EK; Nibbering PH
    J Nucl Med; 2001 May; 42(5):788-94. PubMed ID: 11337578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiolabelled antimicrobial peptides for infection detection.
    Lupetti A; Welling MM; Pauwels EK; Nibbering PH
    Lancet Infect Dis; 2003 Apr; 3(4):223-9. PubMed ID: 12679265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Various routes of administration of (99m)Tc-labeled synthetic lactoferrin antimicrobial peptide hLF 1-11 enables monitoring and effective killing of multidrug-resistant Staphylococcus aureus infections in mice.
    Brouwer CP; Welling MM
    Peptides; 2008 Jul; 29(7):1109-17. PubMed ID: 18423795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiochemical and biological characteristics of 99mTc-UBI 29-41 for imaging of bacterial infections.
    Welling MM; Mongera S; Lupetti A; Balter HS; Bonetto V; Mazzi U; Pauwels EK; Nibbering PH
    Nucl Med Biol; 2002 May; 29(4):413-22. PubMed ID: 12031876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of sites of infection in mice using 99mTc-labeled PN(2)S-PEG conjugated to UBI and 99mTc-UBI: a comparative biodistribution study.
    Meléndez-Alafort L; Nadali A; Pasut G; Zangoni E; De Caro R; Cariolato L; Giron MC; Castagliuolo I; Veronese FM; Mazzi U
    Nucl Med Biol; 2009 Jan; 36(1):57-64. PubMed ID: 19181269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations.
    Welling MM; Paulusma-Annema A; Balter HS; Pauwels EK; Nibbering PH
    Eur J Nucl Med; 2000 Mar; 27(3):292-301. PubMed ID: 10774881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic peptides derived from human antimicrobial peptide ubiquicidin accumulate at sites of infections and eradicate (multi-drug resistant) Staphylococcus aureus in mice.
    Brouwer CP; Bogaards SJ; Wulferink M; Velders MP; Welling MM
    Peptides; 2006 Nov; 27(11):2585-91. PubMed ID: 16814900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cationic antimicrobial peptides and their multifunctional role in the immune system.
    Scott MG; Hancock RE
    Crit Rev Immunol; 2000; 20(5):407-31. PubMed ID: 11145218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and development of a synthetic peptide derived from lactoferrin for clinical use.
    Brouwer CP; Rahman M; Welling MM
    Peptides; 2011 Sep; 32(9):1953-63. PubMed ID: 21827807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro pharmacokinetics of antimicrobial cationic peptides alone and in combination with antibiotics against methicillin resistant Staphylococcus aureus biofilms.
    Dosler S; Mataraci E
    Peptides; 2013 Nov; 49():53-8. PubMed ID: 23988790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activity of de novo designed cationic peptides against multi-resistant clinical isolates.
    Faccone D; Veliz O; Corso A; Noguera M; Martínez M; Payes C; Semorile L; Maffía PC
    Eur J Med Chem; 2014 Jan; 71():31-5. PubMed ID: 24269514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial peptides: their physicochemical properties and therapeutic application.
    Kang SJ; Kim DH; Mishig-Ochir T; Lee BJ
    Arch Pharm Res; 2012 Mar; 35(3):409-13. PubMed ID: 22477186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Physiologic and pathophysiologic significance of antimicrobial (host defensive) small peptides].
    Lapis K
    Orv Hetil; 2008 Dec; 149(51):2419-24. PubMed ID: 19073453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial activities and membrane-active mechanism of CPF-C1 against multidrug-resistant bacteria, a novel antimicrobial peptide derived from skin secretions of the tetraploid frog Xenopus clivii.
    Xie J; Gou Y; Zhao Q; Wang K; Yang X; Yan J; Zhang W; Zhang B; Ma C; Wang R
    J Pept Sci; 2014 Nov; 20(11):876-84. PubMed ID: 25098547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short linear cationic antimicrobial peptides: screening, optimizing, and prediction.
    Hilpert K; Fjell CD; Cherkasov A
    Methods Mol Biol; 2008; 494():127-59. PubMed ID: 18726572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens.
    Romani AA; Baroni MC; Taddei S; Ghidini F; Sansoni P; Cavirani S; Cabassi CS
    J Pept Sci; 2013 Sep; 19(9):554-65. PubMed ID: 23893489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.